Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Receptors for AMPA are ionotropic glutamate receptors with critical roles in neurological development and function.1,2,3 Cyclothiazide is a benzothiadiazide that acts as a potentiator of AMPA receptors, positively modulating its response to glutamic acid (EC50 = 3.8 µM).4,5,6 It blocks the rapid agonist-induced desensitization of AMPA receptors, resulting in enhanced excitatory activity.6 Cyclothiazide is also a negative modulator of GABAA receptors, reversibly inhibiting both evoked and spontaneous inhibitory postsynaptic currents (IC50 = 58 µM).7,8
WARNING This product is not for human or veterinary use.
1. Structure and function of AMPA receptors. J. Physiol. 554(2), 249-253 (2004).
2. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 299(1), 12-20 (2001).
3. Postsynaptic organization and regulation of excitatory synapses. Nat. Rev. Neurosci. 1(2), 133-141 (2000).
4. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11(6), 1069-1082 (1993).
5. Biarylpropylsulfonamides as novel, potent potentiators of 2-
6. Ligands for glutamate receptors: Design and therapeutic prospects. J. Med. Chem. 43(14), 2609-2645 (2000).
7. Cyclothiazide potently inhibits γ-
8. Neurochemicals for the investigation of GABAC receptors. Neurochem. Res. 35(12), 1970-1977 (2010).